Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Vosaroxin

EU orphan designation number: EU/3/12/990   
Active ingredient: Vosaroxin
Indication: Treatment of acute myeloid leukaemia
Sponsor: Sunesis Europe Ltd
Global House, Sandy's Row, London E1 7HW, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/04/2012 Centralised Orphan - Designation EMA/OD/158/11 (2012)2986 of 26/04/2012